Sharpens Focus on Engaged Communities and Prioritizes High-Margin Revenue for Enhanced Profitability Announces Date for Fourth Quarter 2023 Earnings LOS ANGELES, […]
TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]